臆断 发表于 2025-3-25 04:37:32

https://doi.org/10.1007/978-3-7908-2066-9nges, especially in severe and very severe patients, is not easily predictable from the improvement in FEV.. This chapter will describe some of the information that support the use of mono- or combined bronchodilator therapy in patients with COPD.

LIEN 发表于 2025-3-25 08:41:28

http://reply.papertrans.cn/23/2265/226401/226401_22.png

绝种 发表于 2025-3-25 13:19:28

http://reply.papertrans.cn/23/2265/226401/226401_23.png

甜食 发表于 2025-3-25 17:52:37

New Anti-inflammatory Drugs for COPD: Is There a Possibility of Developing Drugs That Can Fundamentaal candidates as anti-inflammatory drugs that would fundamentally suppress airway inflammation in COPD and might prevent progression of COPD. This chapter discusses some of the most promising new therapeutic drugs that have been discovered and describes the status of development of anti-inflammatory drugs in the field of COPD.

Rustproof 发表于 2025-3-25 23:19:04

http://reply.papertrans.cn/23/2265/226401/226401_25.png

Texture 发表于 2025-3-26 01:39:26

http://reply.papertrans.cn/23/2265/226401/226401_26.png

不再流行 发表于 2025-3-26 07:15:34

http://reply.papertrans.cn/23/2265/226401/226401_27.png

Spangle 发表于 2025-3-26 09:52:20

http://reply.papertrans.cn/23/2265/226401/226401_28.png

吃掉 发表于 2025-3-26 12:41:59

2509-5552 trates some comorbidities and associations with other respirThis book considers chronic obstructive pulmonary disease (COPD) not as a simple inflammation of the lung but as a systemic inflammatory disease. Beginning with epidemiological studies, etiology, diagnosis and treatment, it elaborates furth

反抗者 发表于 2025-3-26 16:57:33

http://reply.papertrans.cn/23/2265/226401/226401_30.png
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Chronic Obstructive Pulmonary Disease; A Systemic Inflammat Hiroyuki Nakamura,Kazutetsu Aoshiba Book 2017 Springer Science+Business Media S